Publications by authors named "Michal Devir"

Claim this Profile
D
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status.
Shai Rosenberg, Michal Devir, Luna Kaduri, Albert Grinshpun, Vardiella Miner

Breast Cancer Res Treat· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53_PROF: a machine learning model to predict impact of missense mutations in TP53.
Gil Ben-Cohen, Flora Doffe, Michal Devir, Bernard Leroy, Thierry Soussi

Brief Bioinform· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes.
Myriam Maoz, Michal Devir, Michal Inbar, Ziva Inbar-Daniel, Dana Sherill-Rofe

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes.
Myriam Maoz, Michal Devir, Michal Inbar, Ziva Inbar-Daniel, Dana Sherill-Rofe

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of cancer-associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering.
Thierry Soussi, Bernard Leroy, Michal Devir, Shai Rosenberg

Hum Mutat· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis